Clomipramine and exposure for obsessive-compulsive rituals: i

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Obsessive-compulsive disorder (OCD) is a chronic mental health condition.
• Ritualistic behaviors are a core symptom of OCD.
• Pharmacological and behavioral therapies are established treatment modalities.

Purpose of the Study:

• To evaluate the efficacy of clomipramine and exposure in vivo for chronic obsessive-compulsive ritualizers.
• To assess the impact of treatment on mood and social adjustment.
• To determine the long-term effects and optimal treatment duration.

Main Methods:

• Forty chronic OCD patients were randomized to clomipramine or placebo for 8 months.
• Sub-group analyses included relaxation and exposure in vivo therapy.
• Double-blind assessments were conducted over 114 weeks.

Main Results:

• Clomipramine significantly improved rituals, mood, and social adjustment in patients with comorbid depression.
• Exposure in vivo yielded lasting improvements in rituals and social adjustment.
• Clomipramine showed a temporary effect, with relapse upon discontinuation and improvement upon re-initiation.

Conclusions:

• Clomipramine is beneficial for OCD ritualizers with depressed mood, potentially requiring long-term treatment and combination with exposure therapy.
• Exposure in vivo is the primary treatment for rituals in patients without depressed mood.
• Clomipramine may enhance treatment adherence for behavioral therapies.